A significant discovery in cancer research is occurring with the use of nanobodies to re-engage mutated p53. This essential malignant protector protein is frequently disabled in many forms of tumors, leading https://thegreatbookmark.com/story21963504/mini-antibodies-reactivate-the-p53-protein-new-new-hope-for-malignant-management